BioSpace News Archive

Deals

Lundbeck Acquires Prexton Therapeutics

Lunbeck is acquiring Prexton Therapeutics BV, a 2012 spinout from Merck KgaA, and its Phase II treatment for Parkinson’s disease.

March 16, 2018
·
2 min read
·
Alex Keown
Drug Development

FDA Gives Go-Ahead for Tetra’s Phase II Trial

Tetra Discovery Partners announced that the FDA had given its Investigational New Drug application the go-ahead for Fragile X Syndrome and potentially other autism spectrum disorders.

March 16, 2018
·
2 min read
·
Mark Terry
Deals

Johnson & Johnson Selling LifeScan Unit for $2.1 Billion

Platinum Equity submitted a binding offer to Johnson & Johnson to buy LifeScan for $2.1 billion.

March 16, 2018
·
3 min read
·
Mark Terry
Drug Development

Adaptimmune Sees Positive Early Results in Cancer Treatment

Adaptimmune reported it saw three partial responses in three of the four myxoid/ round cell liposarcoma (MRCLS) patients the company dosed with its NY-ESO SPEAR T-cells.

March 16, 2018
·
2 min read
·
Alex Keown
Business

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

March 16, 2018
·
2 min read
·
Mark Terry
Drug Development

AMO Pharma Sees Positive Results in Phase II Trials

AMO Pharma reported that patients treated with its Phase II neuromuscular treatment for onset myotonic dystrophy type 1 experienced clinical benefits such as an improvement in cognitive function and an increased ability to perform daily tasks.

March 16, 2018
·
2 min read
·
Alex Keown
Biotech Bay

Theranos Serves as a Cautionary Tale for Biotech Funding

There are dangers in biotech funding and Theranos should serve as a warning.

March 16, 2018
·
2 min read
·
Alex Keown
Business

Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan

Chugai to Commercialize Foundation Medicine’s Suite of Comprehensive Genomic Profiling (CGP) Services in Japan, Expanding Patient Access to Personalized Cancer Care

March 16, 2018
·
7 min read
Business

Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany

New site will support complex clinical research and bring more than 200 new jobs to community.

March 16, 2018
·
2 min read
Deals

Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion.

March 16, 2018
·
4 min read